TickerGuard
Buy Day today: Good (62) Broad market participation · no major macro event
AXSM

Axsome Therapeutics Inc

Healthcare · Biotechnology

214.30$ +1.1% vs. previous close Closing price · As of: Sep 17, 2026

Ownership

Ownership Structure

Who owns Axsome Therapeutics Inc (AXSM)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 84.9% of the shares are freely tradable; institutional investors hold 76.6%.

Institutional ownership ?Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings. 76.6%
Insiders ?Share of the stock held by the executives, founders and major shareholders of the company itself. 15.4%
Float ?Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders. 84.9%
Short % of float ?Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices. 9.1%
Shares Outstanding ?Total number of shares issued. Price times share count gives market cap. 52Mio.

Largest Shareholders

Institutions

Institutions AXSM
Name Stake (%) Shares Change (%) Date
BlackRock Inc 7.47 3,912,844 +0.0 03/31/2026
Vanguard Portfolio Management, LLC 3.93 2,058,170 +0.0 03/31/2026
Vanguard Capital Management, LLC 3.70 1,937,752 +0.0 03/31/2026
FMR Inc 2.99 1,566,995 +32.6 03/31/2026
T. Rowe Price Associates, Inc. 2.51 1,317,059 -12.8 03/31/2026
Amvescap Plc. 2.48 1,297,678 +1.9 03/31/2026
Geode Capital Management, LLC 2.22 1,162,981 +15.1 03/31/2026
State Street Corp 1.88 986,809 +3.0 03/31/2026

Funds

Funds AXSM
Name Stake (%) Shares Change (%) Date
Vanguard MStar Total Stk Mkt Idx Invest 2.66 1,393,414 +0.3 07/31/2026
Vanguard Small Cap Index 1.92 1,004,997 +0.2 07/31/2026

Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.

Insider holdings

Insider holdings AXSM
Person Role Shares Value As of Type
Tabuteau Herriot Chief Executive Officer 7,229 1,549,175 $ Aug 6, 2026 direct

Holdings as of each person's most recent SEC Form 4 filing — excluding options and RSUs, which are not shares yet. Holdings may have changed between two filings.

Insiders

Insider Transactions

Insider Transactions
Date Person Role Type Shares Price Value
Sep 3, 2026 Jacobson Mark L. Chief Operating Officer Sell 10,000 208.65 2,086,500
Sep 3, 2026 Jacobson Mark L. Chief Operating Officer Other 10,000 12.95 129,500
Aug 6, 2026 Tabuteau Herriot Chief Executive Officer Sell 4,660 213.95 997,007
Aug 6, 2026 Tabuteau Herriot Chief Executive Officer Other 4,660 4.95 23,067
Aug 5, 2026 Tabuteau Herriot Chief Executive Officer Sell 45,004 212.01 9,541,298
Aug 5, 2026 Tabuteau Herriot Chief Executive Officer Other 45,004 4.95 222,770
Apr 22, 2026 Ari Maizel Insider Sell 7,500 182.42 1,368,150

Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character. View all insider transactions →

Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?